Axol Bioscience Launches Human iPSC-derived Microglia

Cambridge, UK – (6th December 2018) – Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease. Microglia are commonly described as the... Read more

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Cambridge, UK – (17th July 2018) – Axol Bioscience, the human cell culture specialist, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease. Generated from the same donor... Read more